Determination of budesonide R (+) and S (-) isomers in pharmaceuticals by thin-layer chromatography with UV densitometric detection

Chromatographia

Volumn 56, Issue 11-12, 2002, Pages 759-762

  Krzek, J ^a,b   Hubicka, U ^a   Dabrowska Tylka, M ^a   Leciejewicz Ziemecka, E ^b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Polish Pharmacopoeia Commission   (Poland)

Author keywords

Budesonide R (+) and S ( ) isomers; Densitometric detection; Thin layer chromatography

Indexed keywords

BUDESONIDE;

ACCURACY; AQUEOUS SOLUTION; ARTICLE; DENSITOMETRY; DRUG DETERMINATION; DRUG STRUCTURE; ISOMERISM; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

EID: 0036911852     PISSN: 00095893     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02492480     Document Type: Article

References (16)

1. Podlewski, J.K.; Chwalibogowska, A. Leki Współczesnej Terapii, Split Trading Sp. z o.o., Warszawa, 2000.
2. Zaja̧c, M.; Pawełczyk, E. Chemia Leków, Akademia Medyczna, Poznan, 2000 (in Polish).
3. th Edition, Council of Europe, Strasbourg 2002.
4. Faouzi, M.A.; Dine, T.; Luyckx, M.; Brunet, C.; Gressier, B.; Cazin, M.; Wallaert, B.; Cazin, J.C. J. Chromatogr. B Biomed. Appl. 1995, 664, 463-7.
5. Kronkrist, K.; Lovgren, Ulf.; Edholm, L.E.; Johansson, G. J. Pharm. Biomed. Anal. 1993, 11, 459-67.
6. Li, Youan, N.; Tattam, B.; Brown, K.F.; Seale, J.P. J. Chromatogr. B Biomed. Appl. 1996, 683, 259-268.
7. Roth, G.; Wikby, A.; Nilsson, L.; Thalen, A. J. Pharm. Sci. 1980, 69, 766-70.
8. Lindberg, C.; Blomqvist, A.; Paulson, J. Biol. Mass Spectrom. 1992, 21, 525-33.
9. Volmer, D.A.; Hui, J.P.M. Rapid Commun. Mass. Spectrom. 1997, 11, 1926-34.
10. Capella-Peiro, M.A.; Gil-Aquasti, M.; Monoferrer-Pons, L.; Esteve-Romero, J. Anal. Chim. Acta 2002, 454, 125-135.
11. Ferenczi-Fodor, K.; Kovacs, J.; Szepesi, G. J. Chromatogr. 1987, 392, 464-9.
12. Atherne, G.W.; Littleton, P.; Thalen, A.; Marks, V. J. Steroid Biochem. 1982, 17, 559-65.
13. The United States Pharmacopoeia/The National Formulary (VSP/NF 19), United States Pharmacopoeial Convention Inc., Rockville, MD, USA, 2000.
14. Pawłaczyk, J. Farmacja Polska 1999, 55, 282-292.
15. Czarnecki, A.; Maciejczyk, A.; Kosek, M.; Mazurek, A. P. Acta Polon. Pharm. 1993, 50, 1-3.
16. FDA's Policy Statment for the Development of New Stereoisomeric Drugs. U.S. Food and Drug Administration, 1992, May.